Prevalence of IDA in pregnancy - Idpas.org

More documents

Recommendations

Info

Risk <strong>of</strong> Adverse Birth Outcomes for Non-Anemic, Iron-Replete Women is Reduced by Iron Supplements for 2-3 Months (Cogswell et al. 2002) Outcome + Iron Placebo Difference Birth wt 3277 3072 206** % low BW 4.3 16.7 -12.4*** Gest. age (wk) 38.9 38.3 0.6* % preterm 12.8 12.5 ns % SGA 6.8 17.7 -10.9*
Maternal CRH <strong>in</strong> pre-term, term, & post-term deliveries McLean et al., 1995
Page 1 and 2: Prevalence of IDA in pregnancy Lind
Page 3 and 4: Trends in the Prevalence of Anemia
Page 5 and 6: Anemia and Indicators of Iron Statu
Page 7 and 8: Anemia and Indicators of Iron Statu
Page 9 and 10: Transferrin receptors in pregnancy
Page 13 and 14: 100 mg/d Fe Improved Infant Serum F
Page 15 and 16: Iron supplementation in pregnancy r
Page 17 and 18: 100 mg/d Fe reduced % anemia in Tan
Page 19 and 20: Non-intervention Studies: Anemia an
Page 21: Recent Intervention Trial Shows Eff
Page 26 and 27: Impact of birth weight on iron stat
Page 28 and 29: Guidelines for Iron Supplementation
Page 30 and 31: • Honduran infants Dewey et al. 1
Page 32 and 33: How can guidelines be improved? •
Page 34: 1. Be more specific about number of
Page 37 and 38: 2. Minimize Side Effects • “The
Page 40 and 41: Unanswered Questions • How much s
Page 42 and 43: Similarities and Differences Betwee
Page 44 and 45: Normal hemoglobin values during pre
Page 46 and 47: Iron Status in Trimester I Predicts
Page 48 and 49: Attributing Mortality to Anemia is
Page 50: Conclusions from Meta-Analysis of D

Prevalence of IDA in pregnancy - Idpas.org

Create successful ePaper yourself

Delete template?

Save as template?